VivoSeq
Other

Valve Surgery

0

Pipeline Programs↗

1

Active Trials↗

0

Companies Involved↗

Valve Surgery is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

75/100

Attrition Rate

14/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

7

clinical trials

Completed3 · 43%
Unknown status2 · 29%
Recruiting1 · 14%
Terminated1 · 14%

Clinical Trials

Trial Activity

7 trials

Effect of Losartan on the Neurohumoral Axis and Ventricular Remodeling of Patients With Severe Aortic Regurgitation Undergoing Valve Surgery.
Recruiting·VVitor Emer Egypto Rosa·Phase 4·NCT07099859·60 enrolled
A Trial to Evaluate the Effect of Rosuvastatin on Inflammation in Patients Undergoing Isolated Cardiac Valve Surgery
Completed·MMcGill University Health Centre/Research Institute of the McGill University Health Centre·Phase 3·NCT01425398·170 enrolled
Levosimendan in High Risk Heart Valve Surgery
Completed·KKuopio University Hospital·Phase 4·NCT00154115·200 enrolled
Effect of Esketamine on Perioperative Negative Mood in Patients Undergoing Cardiac Valve Surgery
Completed·—·N/A·NCT06608030·142 enrolled
RiaSTAP vs. Conventional Transfusion in Patients Having Heart Valve Surgery
Terminated·EEmory University·Phase 2·NCT01283321·26 enrolled
Sodium Creatine Phosphate in Heart Valve Surgery
Unknown status·—·N/A·NCT03186053·250 enrolled
Continuation of Aspirin Before Isolated Heart Valve Surgery
Unknown status·UUniversity of Liege·N/A·NCT05151796·500 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)